Reversal of Opioid Intoxication in an Infant With Intrauterine Growth Restriction With a Single Dose of Naloxone

Utsav Timalsina1, Ann Andrasovich1, Fernanda E Kupferman1

  • 1Pediatrics, Brookdale University Hospital Medical Center, Brooklyn, USA.

Cureus
|November 22, 2021
PubMed

Insights

Naloxone may be cautiously used in newborns with opioid exposure and respiratory distress, especially those with intrauterine growth restriction (IUGR). This case highlights its potential benefit when administered carefully to opioid-intoxicated infants.

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Developmental Pediatrics

Background:

  • Perinatal opioid exposure can lead to neonatal opioid intoxication.
  • Routine naloxone use in newborns is generally discouraged due to risks of withdrawal and developmental issues.
  • Intrauterine growth restriction (IUGR) presents unique challenges in neonatal care.

Observation:

  • A neonate with IUGR exposed to opioids in utero presented with respiratory and neurological depression at birth.
  • Initial positive pressure ventilation improved the infant's tone and respiratory effort.
  • Delayed bradypnea, shallow breathing, and oxygen desaturation occurred eight hours after birth.

Findings:

  • A single dose of intravenous naloxone successfully reversed the respiratory and neurological depression.
  • The infant, exposed to hydromorphone, showed significant improvement post-naloxone administration.
  • The infant was discharged on day seven with no residual symptoms.

Implications:

  • Naloxone administration may be considered for IUGR infants with persistent cardiorespiratory and neurological depression following recent intrauterine opioid exposure.
  • Careful consideration is needed, particularly if the mother is not narcotic dependent.
  • This case suggests a potential role for naloxone in specific neonatal opioid intoxication scenarios.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
502
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
450
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
326
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
374
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K